FDA Exposure: The AI Health Valuation Red Flag
The burgeoning landscape of AI in healthcare presents a tantalizing prospect for investors: transformative technologies capable of reshaping diagnostics, treatment, and patient outcomes. Yet, beneath…
The burgeoning landscape of AI in healthcare presents a paradox: immense potential for improved patient outcomes, yet significant regulatory and commercial hurdles for innovators. For…